Skip to main content

Table 1 Demographics and baseline characteristics (ITT population)

From: A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic–pituitary–adrenocortical axis of children with asthma

Demographic characteristicPlacebo group N = 55FF 50 QD group N = 56Total N = 111
Age (years)
 Mean (SD)8.4 (2.00)8.4 (1.97)8.4 (1.97)
 Min., Max.5, 115, 115, 11
Age group (years)
 5–< 819 (35)20 (36)39 (35)
 8–< 1236 (65)36 (64)72 (65)
Sex
 Female30 (55)20 (36)50 (45)
 Male25 (45)36 (64)61 (55)
Height (cm)
 Mean (SD)134.6 (14.37)135.3 (15.10)135.0 (14.68)
 Min., Max.106, 161100, 173100, 173
Weight (kg)
 Mean (SD)35.88 (14.338)35.83 (15.054)35.86 (14.637)
 Min., Max.18.5, 71.517.2, 87.717.2, 87.7
  1. Values are n (%), unless otherwise stated, where n represents the number of subjects
  2. FF 50 QD fluticasone furoate 50 µg once daily, ITT intent-to-treat, Min. minimum, Max. maximum, SD standard deviation